FABTECH vs VIVIMEDLAB: Stock Comparison

Fabtech Technologies Limited vs Vivimed Labs LimitedUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Fabtech Technologies Limited is the larger company by market capitalisation. Fabtech Technologies Limited shows a higher dividend yield, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FABTECH leads 7; VIVIMEDLAB leads 0 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FABTECHVIVIMEDLAB

Valuation lens

What price are you paying?

Market CapContext only
₹659 Cr
₹55 Cr
P/E RatioSame reading
13.38x
P/B RatioSame reading
1.55x
EPSFABTECH has the higher reading
₹10.95
₹-2.92
Book ValueContext only
₹109.44
₹4.75
Dividend YieldFABTECH has the higher reading
0.41%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FABTECH is the larger company
₹659 Cr vs ₹55 Cr
EPS
FABTECH has higher earnings per share
₹10.95 vs ₹-2.92
Dividend Yield
FABTECH has a higher dividend yield
0.41% vs 0%
Revenue Growth (TTM YoY)
FABTECH has faster revenue growth
17.5% vs -22.42%
EPS Growth (TTM YoY)
FABTECH has faster EPS growth
23.4% vs 0%
ROCE
FABTECH has a higher ROCE
13.6% vs 0%
Net Margin
FABTECH has a higher net margin
11.28% vs -27.09%
Operating Margin
FABTECH has a higher operating margin
8.52% vs -24.46%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFABTECHVIVIMEDLAB
SectorHealthcareHealthcare
IndustryMedical Equipment & SuppliesPharmaceuticals

Price

MetricFABTECHVIVIMEDLAB
Live Price₹147.62₹7.39
Day Change0.39%-3.15%
Volume1.64 L1.47 L
52-Week High₹262.8₹20.59
52-Week Low₹132.7₹5.15
Distance from 52W High-43.83%-64.11%

Valuation

MetricFABTECHVIVIMEDLAB
Market Cap₹659 Cr₹55 Cr
P/E Ratio13.38x
P/B Ratio1.55x
EPS₹10.95₹-2.92
Book Value₹109.44₹4.75
Dividend Yield0.41%0%

Growth

MetricFABTECHVIVIMEDLAB
Revenue Growth (TTM YoY)17.5%-22.42%
EPS Growth (TTM YoY)23.4%0%
Qtr Sales Growth17.5%
Qtr Profit Growth46.2%

Profitability & Leverage

MetricFABTECHVIVIMEDLAB
ROE12.5%
ROCE13.6%0%
Net Margin11.28%-27.09%
Operating Margin8.52%-24.46%
Debt to Equity0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFABTECHVIVIMEDLAB
Promoter Holding68.94%7.57% 0.2 pp
FII Holding0.02% 0.06 pp1.64%
DII Holding2.45% 0.3 pp0%
Public Holding28.58% 0.25 pp90.67% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fabtech Technologies Limited and Vivimed Labs Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.